Newsletters

  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
R&D Insight

Novo REPAIR Impact Fund is open for EU proposals: 10 May 2019 deadline

Dear All: The Novo REPAIR Impact Fund is open for its second round of EU-based proposals! Four projects have been funded ...
Read More >
FDAR&D Insight

Duration of antibiotic dosing in veterinary medicine / Follow-up comment on FDA AMDAC on IM Bacitracin

Addendum: This is the second in a series of newsletters on IM bacitracin. Go here for the prior newsletter and ...
Read More >
FDAMeetings

12 July 2019 FDA public meeting for comments on the 2018 LPAD guidance

Dear All: Apologies for the back-to-back emails, but this one just came across the transom. In brief, FDA will hold a ...
Read More >
R&D Insight

Mandatory reading: Alan Carr’s in-depth review of the antibiotic landscape

Dear All: Alan Carr (acarr@needhamco.com, Needham & Company, LLC) writes a superb investment-focused newsletter focused on the antibiotic sector. We ...
Read More >
FDAR&D Insight

FDA Antimicrobial Drugs Advisory Committee (AMDAC) on 26 Apr 2019: IM Bacitracin for staphylococcal pneumonia and empyema in infants?!

Addendum: This is the first of a series of newsletters on IM bacitracin. Go here for the next newsletter. Dear ...
Read More >
FDAR&D Insight

IDSA’s 10×20 could be 20×20 and yet not enough! / Harvard course on FDA and prescription drugs

Dear All: Two things on a Friday: First, I just learned of IDSA’s release of its latest paper (link) in the ...
Read More >
R&D Insight

Funding, Filing, and Finance: Most current update of this lecture

Dear All: I had the opportunity today to share an updated version of my “Funding, Filing, and Finance” talk with ...
Read More >
JobsWellcome Trust

Full-time role at Wellcome Trust: Science Innovation Lead for the Drug-Resistant Infections program

Dear All: Wellcome Trust (WT) is seeking a Science Lead for WT’s Drug-Resistant Program (DRI) programme. This is a very senior role ...
Read More >
R&D Insight

Pipelines & scorecards: Perspectives from Pew, JPIAMR, and Access to Medicine Foundation

Dear All: Today we have a new pipeline summary from the Pew Trusts and news about important global scorecards from ...
Read More >
FDAMeetings

FDA workshop: Clinical trial designs for agents for non-tuberculous mycobacterial infection on 8 Apr 2019

 REDear All: I just heard to today that FDA is holding a public workshop entitled “Development of Antibacterial Drugs for ...
Read More >
CARB-XJobs

Great job opportunity in Boston: CARB-X seeks an additional Director of R&D

Dear All: CARB-X is looking for you! This new job was just now posted: The Director of R&D is a new senior role ...
Read More >
FDAR&D Insight

FDA in India / Longitude Prize events / NIAID seeks vaccines & therapeutics for AMR

Dear All: Here’s a potpourri today of several new entries in the forward meetings list below my signature. First, the US FDA ...
Read More >
Wonkish

Modeling the value of an effective antibiotic — Megiddo et al.

Dear All: I have previously written about the challenge of applying health technology assessment (HTA) to estimate the monetary value of an ...
Read More >
R&D Insight

NIAID seeks your comments as it updates its strategic research framework

Dear All: In 2014, NIAID set out a 5-year strategic framework for research on Antimicrobial Resistance (download it here). That document laid out ...
Read More >
Government ActionPush/Pull

Let’s make a pull incentive happen in the US during the 116th Congress!

Dear All: I’ve written a lot about the need for pull incentives, preferably delinked (some papers to read, comments by TATFAR, highlights ...
Read More >
JobsWHO

Short-term WHO role to support analysis of pre-clinical pipeline

Dear All: I wrote previously (link to newsletter) about WHO’s call for information about pre-clinical antibiotic R&D. With a due ...
Read More >
R&D InsightSomething Different

Read, watch, learn, & share: Excellent BBC documentary, CID 10×20 update, BARDA director interview

Dear All: Great stuff to read, watch, and share! First, there is an excellent new BBC documentary entitled The Truth About ...
Read More >
R&D Insight

NDM-1 in the Arctic / IACG seeks your views!

Dear All: Apologies for inundating with updates … the last few days have been very data rich! In case you ...
Read More >
R&D InsightWHO

WHO wants to hear from all pre-clinical antibiotic developers (18 Mar 2019 deadline)

​Dear All: Are you doing preclinical antibiotic R&D? If so, WHO wants to hear from you! As you know, WHO ...
Read More >
Government ActionR&D Insight

Draft EMA antibacterial guidance: Analysis

Dear All: I wrote previously that EMA posted an extensively updated and consolidated version of their previously separate Guideline (CPMP/EWP/558/95 Rev.2) and ...
Read More >
Scroll to Top